Overview
The links in this Patient Care section describe the Stanford BMT Program and the transplant process as described in our program brochure. For a downloadable version of the Program brochure, click below. This is a large file and may take some time to download.
Program Overview
Since the program’s inception in 1987 over 3500 adult patients have received transplants for a variety of malignant and non-malignant diseases including lymphoma, myeloma, leukemia, myelodysplastic syndrome and selected solid tumors. We currently provide transplants to over 200 patients each year.
Our nationally recognized program combines superior patient care with cutting-edge medicine. We are among a select number of BMT programs in the country currently funded by the National Cancer Institute (NCI) to conduct clinical research designed to improve patient outcomes. The program is fully accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and is a member of the BMT Clinical Trials Network of the NCI. The Stanford Cellular Therapeutics and Transplantation Laboratory is operated by the BMT Program and processes blood and marrow products for transplantation.
Patients receiving care with the BMT Program have access to the full complement of specialist physicians within the medical center, including many who are nationally recognized. Although most of our patients are from California others travel from throughout the United States and some from other countries to seek care from the Stanford BMT Program.
BMT Intranet